Charles Schwab’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.58M Sell
517,162
-1,779
-0.3% -$8.86K ﹤0.01% 2594
2025
Q1
$2.29M Sell
518,941
-19,647
-4% -$86.6K ﹤0.01% 2565
2024
Q4
$2.5M Buy
538,588
+58,465
+12% +$272K ﹤0.01% 2609
2024
Q3
$3.33M Buy
480,123
+26,262
+6% +$182K ﹤0.01% 2551
2024
Q2
$3.54M Buy
453,861
+14,999
+3% +$117K ﹤0.01% 2510
2024
Q1
$3.12M Buy
438,862
+565
+0.1% +$4.01K ﹤0.01% 2461
2023
Q4
$2.94M Buy
438,297
+21,557
+5% +$144K ﹤0.01% 2507
2023
Q3
$2.35M Buy
416,740
+26,832
+7% +$151K ﹤0.01% 2551
2023
Q2
$2.15M Buy
389,908
+76,005
+24% +$420K ﹤0.01% 2524
2023
Q1
$1.96M Sell
313,903
-67,091
-18% -$419K ﹤0.01% 2527
2022
Q4
$1.78M Sell
380,994
-2,282
-0.6% -$10.6K ﹤0.01% 2603
2022
Q3
$1.79M Buy
383,276
+40,516
+12% +$189K ﹤0.01% 2613
2022
Q2
$2.03M Sell
342,760
-5,717
-2% -$33.9K ﹤0.01% 2563
2022
Q1
$6.74M Buy
348,477
+35,130
+11% +$679K ﹤0.01% 2141
2021
Q4
$10.2M Buy
313,347
+3,128
+1% +$102K ﹤0.01% 1984
2021
Q3
$12.7M Buy
310,219
+10,231
+3% +$420K ﹤0.01% 1868
2021
Q2
$10.8M Buy
299,988
+115,139
+62% +$4.15M ﹤0.01% 1953
2021
Q1
$7.21M Buy
184,849
+6,189
+3% +$242K ﹤0.01% 2122
2020
Q4
$7.21M Buy
+178,660
New +$7.21M ﹤0.01% 2044